BACKGROUND: Several sickle cell clinical trials have closed due to inability to enroll patients. To limit the early cessation of a proposed clinical trial due to low accrual rates, we sought to better understand barriers and facilitators to enrolling parents of children with sickle cell anemia (SCD) into clinical trials. PROCEDURE: Focus groups (n = 3) were conducted with parents/guardians (n = 14) who had not previously been recruited for a clinical trial and were not administering hydroxyurea to their children. RESULTS: Three main themes related to barriers to clinical trial enrollment were identified during analysis of focus groups: general barriers to health related research (general mistrust of research studies, emotional and practical concerns), barriers to trial design (randomization), and barriers to hydroxyurea (long term unknown risks, cancer, myelosuppressive effects). Facilitators identified were need for more education, including request for peer education, and improved explanation of clinical trials or study rationale. CONCLUSION: Engagement of parents/guardians of children withSCD in identifying barriers and facilitators to clinical trial enrollment may be critical to the development of strategies to enhance SCD trial completion.
RCT Entities:
BACKGROUND: Several sickle cell clinical trials have closed due to inability to enroll patients. To limit the early cessation of a proposed clinical trial due to low accrual rates, we sought to better understand barriers and facilitators to enrolling parents of children with sickle cell anemia (SCD) into clinical trials. PROCEDURE: Focus groups (n = 3) were conducted with parents/guardians (n = 14) who had not previously been recruited for a clinical trial and were not administering hydroxyurea to their children. RESULTS: Three main themes related to barriers to clinical trial enrollment were identified during analysis of focus groups: general barriers to health related research (general mistrust of research studies, emotional and practical concerns), barriers to trial design (randomization), and barriers to hydroxyurea (long term unknown risks, cancer, myelosuppressive effects). Facilitators identified were need for more education, including request for peer education, and improved explanation of clinical trials or study rationale. CONCLUSION: Engagement of parents/guardians of children with SCD in identifying barriers and facilitators to clinical trial enrollment may be critical to the development of strategies to enhance SCD trial completion.
Authors: Winfred C Wang; Russell E Ware; Scott T Miller; Rathi V Iyer; James F Casella; Caterina P Minniti; Sohail Rana; Courtney D Thornburg; Zora R Rogers; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada A Sarnaik; Thomas H Howard; Lynn W Wynn; Abdullah Kutlar; F Daniel Armstrong; Beatrice A Files; Jonathan C Goldsmith; Myron A Waclawiw; Xiangke Huang; Bruce W Thompson Journal: Lancet Date: 2011-05-14 Impact factor: 79.321
Authors: Anjali S Advani; Benjamin Atkeson; Carrie L Brown; Bercedis L Peterson; Laura Fish; Jeffrey L Johnson; Jon P Gockerman; Marc Gautier Journal: Cancer Date: 2003-03-15 Impact factor: 6.860
Authors: Marlene H Peters-Lawrence; Margaret C Bell; Lewis L Hsu; Ifeyinwa Osunkwo; Phillip Seaman; Miren Blackwood; Edouard Guillaume; Rita Bellevue; Lakshmanan Krishnamurti; Wally R Smith; Carlton D Dampier; Caterina P Minniti Journal: Contemp Clin Trials Date: 2011-12-02 Impact factor: 2.226
Authors: Lori Styles; Carrie G Wager; Richard J Labotka; Kim Smith-Whitley; Alexis A Thompson; Peter A Lane; Lillian E C McMahon; Robin Miller; Susan D Roseff; Rathi V Iyer; Lewis L Hsu; Oswaldo L Castro; Kenneth I Ataga; Onyinye Onyekwere; Maureen Okam; Rita Bellevue; Scott T Miller Journal: Br J Haematol Date: 2012-03-30 Impact factor: 6.998
Authors: Michael R DeBaun; Sharada A Sarnaik; Mark J Rodeghier; Caterina P Minniti; Thomas H Howard; Rathi V Iyer; Baba Inusa; Paul T Telfer; Melanie Kirby-Allen; Charles T Quinn; Françoise Bernaudin; Gladstone Airewele; Gerald M Woods; Julie Ann Panepinto; Beng Fuh; Janet K Kwiatkowski; Allison A King; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Hernan Sabio; Corina E Gonzalez; Suzanne L Saccente; Karen A Kalinyak; John J Strouse; Jason M Fixler; Mae O Gordon; J Phillip Miller; Michael J Noetzel; Rebecca N Ichord; James F Casella Journal: Blood Date: 2011-11-17 Impact factor: 22.113
Authors: J M Falletta; G M Woods; J I Verter; G R Buchanan; C H Pegelow; R V Iyer; S T Miller; C T Holbrook; T R Kinney; E Vichinsky Journal: J Pediatr Date: 1995-11 Impact factor: 4.406
Authors: Joel B Braunstein; Noëlle S Sherber; Steven P Schulman; Eric L Ding; Neil R Powe Journal: Medicine (Baltimore) Date: 2008-01 Impact factor: 1.889
Authors: Robert S Nickel; Ifeyinwa Osunkwo; Aneesah Garrett; Jennifer Robertson; David R Archer; Daniel E L Promislow; John T Horan; Jeanne E Hendrickson; Leslie S Kean Journal: Br J Haematol Date: 2015-03-05 Impact factor: 6.998
Authors: Oluwakemi Badaki-Makun; J Paul Scott; Julie A Panepinto; T Charles Casper; Cheryl A Hillery; J Michael Dean; David C Brousseau Journal: Pediatr Blood Cancer Date: 2014-01-17 Impact factor: 3.167
Authors: Evelyn M Stevens; Chavis A Patterson; Yimei B Li; Kim Smith-Whitley; Lamia P Barakat Journal: Am J Prev Med Date: 2016-07 Impact factor: 5.043
Authors: Susan E Creary; Avani C Modi; Joseph R Stanek; Deena J Chisolm; Sarah H O'Brien; Cara Nwankwo; Lori E Crosby Journal: J Pediatr Psychol Date: 2019-11-01
Authors: Jeffrey D Lebensburger; Lee M Hilliard; Lauren E Pair; Robert Oster; Thomas H Howard; Gary R Cutter Journal: Clin Trials Date: 2015-06-17 Impact factor: 2.486
Authors: C Byrnes; M Botello-Harbaum; T Clemons; L Bailey; K M Valdes; V H Coleman-Cowger Journal: J Natl Med Assoc Date: 2022-01-31 Impact factor: 1.798
Authors: Jane S Hankins; Mary Beth McCarville; Angela Rankine-Mullings; Marvin E Reid; Clarisse L C Lobo; Patricia G Moura; Susanna Ali; Deanne P Soares; Karen Aldred; Dennis W Jay; Banu Aygun; John Bennett; Guolian Kang; Jonathan C Goldsmith; Matthew P Smeltzer; James M Boyett; Russell E Ware Journal: Am J Hematol Date: 2015-11-17 Impact factor: 10.047
Authors: Andrew R Wong; Virginia Sun; Kevin George; Jennifer Liu; Simran Padam; Brandon A Chen; Thomas George; Arya Amini; Daneng Li; Mina S Sedrak Journal: JCO Oncol Pract Date: 2020-04-02